FHI 360 is a global organization that mobilizes research, resources and relationships so that people everywhere can access the opportunities they need to lead full, healthy lives.  For more than 50 years, we have worked to develop bold solutions to global challenges and create measurable results through research and application of scientific breakthroughs. We listen to, learn from and work with communities to expand social and economic opportunity, improve health and well-being, respond to humanitarian crises.

Since 1977, FHI 360 Nepal has been a trusted partner in transforming the country’s health and development landscape. Leveraging a blend of global expertise and local insights, we have consistently strengthened community capacities, enhanced systems, and reinforced institutional frameworks for sustainable impact. In close partnership with the Government of Nepal (GoN), civil society, academia, and the private sector, FHI 360 Nepal delivers integrated programs across critical sectors. Our initiatives span essential health services—including HIV, maternal, newborn and child health (MNCH) and nutrition—procurement and supply chain management (PSM) for life-saving drugs, global health security (GHS)—including laboratory strengthening, antimicrobial resistance (AMR), disease surveillance, evidence-based public health messaging and community engagement, and health emergency management—and air quality management.

The U.S. government’s (USG) GHS program provides life-saving assistance to prevent, detect, and respond to infectious disease threats which pose risks for public health outbreaks that could cost lives. As part of the USG’s GHS program, the STRengthening Infectious disease DEtection Systems (STRIDES) Activity advances cross-sectoral efforts to successfully identify, manage, and respond to infectious disease threats; detect and prevent further outbreaks; and instill confidence and trust in a country’s disease detection and surveillance structures and services.

We request applications from qualified individuals for the positions mentioned below:

Position: Laboratory and Diagnostic Advisor

 Position Summary: The Laboratory and Diagnostics Advisor will provide technical leadership and guidance to support the staff and projects for the US Department of State (DOS)-funded STRIDES activity for the laboratory and diagnostic components in Nepal. The position will lead and manage the development, implementation, and monitoring of strategic and technical initiatives to strengthen laboratory systems and diagnostic capacities and provide technical guidance around the issues, challenges, and strategies for building laboratory capacity in Nepal and improving access to quality diagnostic testing related to project activities. The Laboratory and Diagnostics Advisor will work closely with country-level teams, including the project management team, project technical providers, and key stakeholders, to ensure the provision of technical assistance to achieve effective, high-quality, and reliable laboratory services. The position will lead the development of guidelines and policies for laboratory diagnostic network strengthening activities, provide technical thought leadership at the regional and country levels, and contribute to the development of project statements of work, work plan development, monitoring and evaluation systems, technical reporting, and other administrative elements of the project.

Key Qualification and experience: Master’s degree in microbiology or other relevant subjects in biological sciences within a clinical or diagnostic discipline or specialty with eight years of experience working with infectious disease diagnostics and/or in laboratory systems strengthening (preferably including microbiology, antimicrobial resistance (AMR)/antimicrobial use (AMU) or disease surveillance).

Please refer to the link below for the complete position description.

Interested eligible Nepali candidates are requested to apply for this job on the link https://www.fhi360.org/careers

The final deadline for application is 5:00 p.m. February 22, 2026.

Only short-listed candidates will be invited for written tests and oral interviews. FHI 360 reserves the right to reject any or all applications received without explanation.